Expert Opinion on Drug Discovery
Volume 19, 2024 - Issue 5
Review
Treatment of highly virulent mammarenavirus infections—status quo and future directions
Ivette A. Nuñeza Integrated Research Facility at Fort Detrick, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD, USA
https://orcid.org/0000-0003-3213-3628View further author information
https://orcid.org/0000-0003-3213-3628View further author information, Anya Cranea Integrated Research Facility at Fort Detrick, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD, USAhttps://orcid.org/0000-0002-2060-2469View further author information
https://orcid.org/0000-0002-2060-2469View further author information, Ian Crozierb Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USAhttps://orcid.org/0000-0003-2485-4011View further author information
https://orcid.org/0000-0003-2485-4011View further author information, Gabriella Worwaa Integrated Research Facility at Fort Detrick, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD, USAhttps://orcid.org/0000-0001-7485-2204View further author information
https://orcid.org/0000-0001-7485-2204View further author information & Jens H. Kuhna Integrated Research Facility at Fort Detrick, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD, USACorrespondence[email protected]
https://orcid.org/0000-0002-7800-6045View further author information
https://orcid.org/0000-0002-7800-6045View further author information